» Articles » PMID: 26955482

The Effects of Dopamine on Digit Span in Parkinson's Disease

Overview
Publisher Biomed Central
Date 2016 Mar 9
PMID 26955482
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial evidence that dopamine also impacts cognition, in particular working memory. It is therefore critical for movement disorders physicians to understand the potential dopaminergic effects on working memory when prescribing these medications. Verbal digit span tasks offer a potentially straightforward and quick assessment of baseline working memory. Moreover, Digit Span Backward was recently validated as a screening tool for mild cognitive impairment in Parkinson's disease when participants were medicated. Research indicates that the interaction between dopamine and working memory follows an Inverted-U shaped curve, but the effect of dopamine on Digit Span has not been well studied. Our study seeks to: (1) determine the validity of verbal Digit Spans for detecting cognitive impairment in Parkinson's disease patients both ON and OFF medications; and (2) ascertain the effects of dopaminergic medications on verbal Digit Span.

Methods: We recruited 64 Parkinson's disease patients and 22 age-and education-matched controls. Parkinson's patients completed Digit Span Backward and Digit Span Forward ON and OFF medications, while healthy controls completed them once. All participants were categorized by cognitive diagnosis using level-II consensus criteria.

Results: Digit Span Backward successfully identified mild cognitive impairment in Parkinson's disease, both ON and OFF medications. Combining patients with and without cognitive impairment, we found that dopamine significantly improved performance on Digit Span Backward, but not Forward. In a secondary analysis, we found this dopaminergic improvement was restricted to the Low baseline working memory group; the High baseline working memory group was unaffected.

Conclusions: This study provides evidence for Digit Span Backward as a screening tool for working memory impairment in Parkinson's disease and for its utility in measuring baseline working memory. Moreover, it reveals a partial beneficial effect of dopamine on Digit Span in Parkinson's disease patients.

Citing Articles

Cognition and Activity of Daily Living Function in people with Parkinson's disease.

Bode M, Kalbe E, Liepelt-Scarfone I J Neural Transm (Vienna). 2024; 131(10):1159-1186.

PMID: 38976044 PMC: 11489248. DOI: 10.1007/s00702-024-02796-w.


The Reflective Mind of the Anxious in Action: Metacognitive Beliefs and Maladaptive Emotional Regulation Strategies Constrain Working Memory Efficiency.

Cecillon F, Mermillod M, Leys C, Bastin H, Lachaux J, Shankland R Eur J Investig Health Psychol Educ. 2024; 14(3):505-530.

PMID: 38534895 PMC: 10968987. DOI: 10.3390/ejihpe14030034.


Clinical evaluation and resting state fMRI analysis of virtual reality based training in Parkinson's disease through a randomized controlled trial.

Hajebrahimi F, Velioglu H, Bayraktaroglu Z, Yilmaz N, Hanoglu L Sci Rep. 2022; 12(1):8024.

PMID: 35577874 PMC: 9110743. DOI: 10.1038/s41598-022-12061-3.


The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.

Mihaila D, Donegan J, Barns S, LaRocca D, Du Q, Zheng D PLoS One. 2019; 14(6):e0218252.

PMID: 31247001 PMC: 6597068. DOI: 10.1371/journal.pone.0218252.


Episodic recognition memory and the hippocampus in Parkinson's disease: A review.

Das T, Hwang J, Poston K Cortex. 2019; 113:191-209.

PMID: 30660957 PMC: 6445686. DOI: 10.1016/j.cortex.2018.11.021.


References
1.
Vijayraghavan S, Wang M, Birnbaum S, Williams G, Arnsten A . Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci. 2007; 10(3):376-84. DOI: 10.1038/nn1846. View

2.
Gibbs S, DEsposito M . Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci. 2005; 5(2):212-21. DOI: 10.3758/cabn.5.2.212. View

3.
Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A . Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease. J Neural Transm (Vienna). 2013; 120(4):627-33. DOI: 10.1007/s00702-013-1004-2. View

4.
Frank M, OReilly R . A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci. 2006; 120(3):497-517. DOI: 10.1037/0735-7044.120.3.497. View

5.
Thanvi B, Munshi S, Vijaykumar N, Lo T . Neuropsychiatric non-motor aspects of Parkinson's disease. Postgrad Med J. 2003; 79(936):561-5. PMC: 1742855. DOI: 10.1136/pmj.79.936.561. View